A Downside to Hepatitis C Virus Cure? Vigilance Is Needed Regarding Hepatitis B Virus Reactivation, Organ Rejection, or Hepatocellular Carcinoma Progression. [electronic resource]
Producer: 20190702Description: 857-860 p. digitalISSN:- 1537-6613
- Antiviral Agents -- therapeutic use
- Carcinoma, Hepatocellular -- etiology
- Graft Rejection -- etiology
- Hepatitis B virus -- physiology
- Hepatitis C -- drug therapy
- Humans
- Immunosuppressive Agents -- administration & dosage
- Liver Neoplasms -- etiology
- Recurrence
- Virus Activation -- drug effects
- Virus Latency -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.